A mitotic phosphorylation feedback network connects Cdk1, Plk1, 53BP1, and Chk2 to inactivate the G(2)/M DNA damage

Marcel A T M van Vugt1, Alexandra K Gardino, Rune Linding

  • 1David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.

Plos Biology
|February 4, 2010
PubMed

Insights

This study reveals how Polo-like kinase 1 (Plk1) regulates DNA damage checkpoints. Plk1 binding to 53BP1 and phosphorylating Chk2 are crucial for inactivating cell cycle arrest and enabling DNA repair completion.

Area of Science:

  • Cellular Biology
  • Molecular Biology
  • Genetics

Background:

  • DNA damage checkpoints are essential for cell survival following genotoxic stress.
  • While checkpoint activation is well-studied, mechanisms for checkpoint maintenance and inactivation remain largely unknown.

Purpose of the Study:

  • To investigate feedback mechanisms controlling DNA damage checkpoint duration.
  • To identify molecular players involved in sustaining and terminating checkpoint signaling.

Main Methods:

  • Computational identification of a conserved mitotic phosphorylation network in DNA damage response.
  • In vivo studies using 53BP1 mutants and analysis of Plk1 interactions.
  • Biochemical assays to assess Chk2 kinase activity and FHA domain function.

Main Results:

  • The checkpoint adaptor protein 53BP1 is a direct in vivo target of Cyclin-dependent kinase-1 and Polo-like kinase-1 (Plk1).
  • Plk1 binding to 53BP1 during mitosis is essential for DNA damage checkpoint inactivation and cell cycle restart.
  • Plk1 phosphorylates and inactivates the checkpoint kinase Chk2, regulating the ATM-Chk2 pathway.

Conclusions:

  • A negative feedback loop mediated by mitotic kinases (Plk1) controls the duration of DNA damage checkpoints.
  • Phosphorylation of 53BP1 and Chk2 by Plk1 is critical for timely checkpoint inactivation and DNA repair.
  • This regulatory mechanism ensures proper cell cycle progression after genotoxic insult.

Related Concept Videos

M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...